Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/2003
06/11/2003EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
06/11/2003EP1317265A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
06/11/2003EP1317208A1 Method for pictorially depicting and diagnosing thrombi by means of nuclear spin tomography involving the use of particulate contrast agents
06/11/2003EP0782863B1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof
06/11/2003EP0731690B1 Liposomes with enhanced entrapment capacity, production and use thereof
06/11/2003CN2555023Y Label for detecting transfer power of digestive canal
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1422669A B-type supersonic resetting image intensifying agent for entembole and preparation technology thereof
06/10/2003US6576811 Transgenic rat with human normal type c-Ha-ras gene
06/10/2003US6576222 Complex stability and specificity; NMR contrast media as diagnostic aid for localization of vascular disease
06/10/2003US6576221 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
06/10/2003US6576220 Non-invasive methods for surgery in the vasculature
06/10/2003US6575910 Ultrasonic image persistence using contrast agents
06/10/2003US6575169 Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
06/10/2003CA2030472C Cascade polymer bound complexing compounds their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
06/05/2003WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells
06/05/2003WO2003045979A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
06/05/2003WO2003045442A1 Metal complex compounds
06/05/2003WO2003045441A1 Contrast agents for the in vivo detection of enzyme activity
06/05/2003WO2003045432A1 Treatment of neovascular ophthalmic disease
06/05/2003WO2003045380A1 Ilk inhibitors for the treatment of renal disease
06/05/2003WO2003045308A2 Formulations for use in medical or diagnostic procedures
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis
06/05/2003US20030105299 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
06/05/2003US20030105163 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
06/05/2003US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
06/05/2003US20030104359 Apparatus for use in the recovery of preferential particles in a sample
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103904 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
06/05/2003US20030103898 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
06/05/2003CA2468197A1 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
06/05/2003CA2466864A1 Treatment of neovascular ophthalmic disease
06/04/2003EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct
06/04/2003EP1316320A1 Preparations for diagnosing extrapancreatic secretory function
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1126782A4 Method for improved imaging and photodynamic therapy
06/04/2003EP0966414B1 Triarylmethyl free radicals as image enhancing agents
06/04/2003EP0656368B2 Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003CN1110473C Method for removing contaminants from products
06/03/2003US6574495 Para-hydrogen labelled agents and their use in magnetic resonance imaging
06/03/2003US6572840 Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
06/03/2003CA2137910C Use of microcapsules as contrasting agents in colour doppler sonography
05/2003
05/30/2003WO2003043663A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/30/2003WO2003043552A1 Methods for initiating in situ formation of hydrogels
05/30/2003WO2003032728A3 Methods for preventing or reversing asthma and compositions useful therefor
05/30/2003WO2003023341A3 Thermographic metthod
05/30/2003WO2003022308A3 Therapeutic insert and therapeutic method
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003CA2467915A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/29/2003US20030101466 Method for screening for agents against cancer using an immunosuppression animal model
05/29/2003US20030100752 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099972 Nucleotide sequences conjugate for use as diagnostic tool in genetic engineering
05/29/2003US20030099764 Providing a coating on the medical device in which a paramagnetic-metal ion/chelate complex is encapsulated by a hydrogel, a chelate being linked to a functional group, and the functional group being an amine group
05/29/2003US20030099662 Proteins
05/29/2003US20030099598 Tissue specific fluorescent chelates possessing long wavelength UV excitation
05/29/2003US20030099597 Novel high viscosity embolizing compositions
05/28/2003EP1314984A2 Highly concentrated Creatininsolutions for use in renal function test
05/28/2003EP1314979A1 Method and device for determining state of skin surface
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313695A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1241986A4 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP0822836B1 Process for producing polymer microparticles, microparticles produced using said process, and the use of such particles in medical diagnostics
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1419939A Spiral CT three-D simulation endoscope contrast medium and producing method thereof
05/27/2003US6571116 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging
05/27/2003US6569451 Targeted polymerized liposome diagnostic and treatment agents
05/27/2003US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+
05/27/2003US6569417 Delivering biocompatible polymer, biocompatible solvent, and contrast agent to periurethral tissue of mammal wherein delivery is conducted under conditions such that polymer precipitate forms in situ in tissue
05/27/2003US6569405 Atomizing solution through an orifice into a gas such that said liquid evaporates thereby forming a powder of hollow microcapsules
05/27/2003US6569404 Aqueous colloidal suspension, dispersed phase is gas microbubbles of perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane or sulfur hexafluoride; fluorinated amphiphile for stabilizing microbubbles
05/27/2003US6569402 Vitronectin receptor antagonist pharmaceuticals
05/22/2003WO2003041740A1 Tumor necrosis agent
05/22/2003WO2003011115A3 Peptide-based multimeric targeted contrast agents
05/22/2003WO2002100353A3 Cd10-activated prodrug compounds
05/22/2003WO2002074339B1 Deveice and method for the photodynamic diagnosis of tumor tissue
05/22/2003US20030096224 Retentate chromatography and protein chip arrays with applications in biology and medicine
05/22/2003US20030095924 Perfluoroalkyl-containing dye molecules used in contrast media for the visualization of lymph nodes.
05/22/2003US20030095923 System for imaging malignant tumors using carbon 13 with MRI
05/22/2003US20030095922 Gadolinium (III) complexes as magnetic resonance imaging contrast enhancers
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1192450A4 High energy phototherapeutic agents
05/21/2003EP1005369B1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
05/21/2003EP0873091B1 Apparatus for marking tissue
05/21/2003CN1108824C Bioactivated diagnostic imaging contrast agents
05/20/2003US6567689 Methods and chemical preparations for time-limited marking of biopsy sites
05/20/2003US6566398 Method for treatment of external secretion disorders
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 354